title: Increased expression of the G gamma and A gamma globin genes associated with a mutation in the A gamma enhancer.
abstract: We have previously described a unique type of delta beta-thalassemia in a Chinese family characterized by increased expression of the G gamma and A gamma fetal globin genes in the absence of a large deletion in the beta-globlin gene cluster. Our earlier study of the beta-globin gene on this delta beta-thalassemia chromosome showed a promoter mutation in the TATA box. In this report, we describe the results of our study of the fetal globin domain of this delta beta-thalassemia chromosome. We have cloned a 13-kb DNA fragment that includes the G gamma and the A gamma genes and the 3' A gamma enhancer element of this delta beta-thalassemia chromosome. DNA sequence analysis of the G gamma and A gamma-globin genes including their promoters did not show any mutations, but analysis of the putative enhancer element downstream from the A gamma-globin gene showed a C to T substitution 2,401 nucleotides downstream from the A gamma cap site. We performed DNA linkage analysis to determine if this mutation is unique to this chromosome or represents a common polymorphism. Our linkage analysis showed that this mutation is not a common polymorphism and that it is also not an intrinsic part of the haplotype of the chromosome on which it was found. We also studied the interaction of nuclear proteins from erythroid and nonerythroid cells with the DNA sequences surrounding this mutation. We have shown by in vitro DNase I footprinting that this mutation falls within a region that is occupied by a novel DNA-binding protein that binds to this site in nuclear extracts from erythroid, but not nonerythroid cells. The binding of this nuclear protein to DNA appears to be dependent on GATA-1 binding to an adjacent GATA-1 site. We have also developed a new functional assay to compare the activity of the normal and mutant A gamma enhancer elements in erythroid cells. Analysis of the activity of the mutant enhancer shows that the mutation completely eliminates all enhancer activity in this assay. These findings suggest that this mutation of the A gamma enhancer on a chromosome that carries a partially inactivated beta-globin gene may be responsible for the increased expression of both gamma-globin genes seen in this condition.
authors.affiliation: Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029.
authors.forename: G
authors.initials: G
authors.lastname: Balta
authors.forename: H E
authors.initials: HE
authors.lastname: Brickner
authors.forename: S
authors.initials: S
authors.lastname: Takegawa
authors.forename: H H
authors.initials: HH
authors.lastname: Kazazian
authors.forename: T
authors.initials: T
authors.lastname: Papayannopoulou
authors.forename: B G
authors.initials: BG
authors.lastname: Forget
authors.forename: G F
authors.initials: GF
authors.lastname: Atweh
mesh_terms: D001483:Base Sequence; D003001:Cloning, Molecular; D003850:Deoxyribonuclease I / Q000494:pharmacology; D004742:Enhancer Elements, Genetic; D005260:Female; D005319:Fetal Hemoglobin / Q000235:genetics*; D008040:Genetic Linkage; D005914:Globins / Q000235:genetics*; D006801:Humans; D006822:Hybrid Cells; D008969:Molecular Sequence Data; D009154:Mutation; D017086:beta-Thalassemia / Q000235:genetics*
chemical_list: D005914:Globins; D005319:Fetal Hemoglobin; D003850:Deoxyribonuclease I